| Literature DB >> 33110098 |
Seiichi Matsumura1,2,3, Yosuke Kurashima4,5,6,7,8, Sayuri Murasaki2, Masako Morimoto1, Fujimi Arai2, Yukari Saito1, Nana Katayama2, Dayoung Kim2, Yutaka Inagaki9, Takahiro Kudo3, Peter B Ernst10,11,12, Toshiaki Shimizu3, Hiroshi Kiyono2,13,10.
Abstract
Mesenchymal cells in the crypt play indispensable roles in the maintenance of intestinal epithelial homeostasis through their contribution to the preservation of stem cells. However, the acquisition properties of the production of stem cell niche factors by the mesenchymal cells have not been well elucidated, due to technical limitations regarding the isolation and subsequent molecular and cellular analyses of cryptal mesenchymal cells. To evaluate the function of mesenchymal cells located at the large intestinal crypt, we established a novel method through which cells are harvested according to the histologic layers of mouse colon, and we compared cellular properties between microenvironmental niches, the luminal mucosa and crypts. The gene expression pattern in the cryptal mesenchymal cells showed that receptors of the hormone/cytokine leptin were highly expressed, and we found a decrease in Wnt2b expression under conditions of leptin receptor deficiency, which also induced a delay in cryptal epithelial proliferation. Our novel stratified layer isolation strategies thus revealed new microenvironmental characteristics of colonic mesenchymal cells, including the intrinsic involvement of leptin in the control of mucosal homeostasis.Entities:
Year: 2020 PMID: 33110098 PMCID: PMC7591933 DOI: 10.1038/s41598-020-75186-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Stratified isolation of mouse colon for microenvironmental cellular analysis. (a) Representative images of hematoxylin and eosin (H and E) staining of whole colon, peeled layers containing mucosa and submucosa, and muscularis externa (MEx) are shown. (b) Representative images of H and E staining of de-epithelialized mucosa, muscularis mucosae (MM) with submucosa, and crypt layer are shown. Bar, 100 μm. (c) Representative images of whole colon, mucosa, MM with submucosa, and MEx from Twist2-Cre tdTomato × Col1a2 GFP mice and stained by using EpCAM are shown. (d) Crypt region of Twist2-Cre tdTomato × Col1a2 GFP mice is shown. Bar, 100 μm. Images representative of at least three independent experiments are shown.
Figure 2Cellular profiling of stratified isolated cell populations. (a) Flow cytometry of stratified isolated cells stained with CD45, EpCAM, and gp38. The number indicates percentages of gated populations. Right data indicates the percentages of each cellular component in the colon microenvironment. Data are shown as means ± SEM. (b) Flow cytometry of cells in each layer is shown. The gp38+ cells in the negative-gated areas for EpCAM, TER119, and CD31 are shown. The number indicates the size (percentage) of the gated population. CD90 and CD34 expression of gated gp38+ cells are shown. (c) gp38+ cells were stained with CD90 and CD34. The numbers indicate the size (percentage) of the gated populations. CD81 expressions were shown in the right panel. All data are representative of at least three independent experiments.
Figure 3LepR expression in cryptal mesenchymal cells. (a–c) gp38+ mesenchymal cells isolated from the cryptal and upper mucosal layers underwent gene microarray analysis (n = 1). (d) Gene expression of leptin receptors in mesenchymal cells sorted from upper mucosa or crypt were examined with that of EpCAM+ epithelial cells and CD45+ lymphocytes by quantitative RT-PCR analysis. *P < 0.05. Each result was normalized against the expression of Gapdh. n.s. indicates not significant. (e) Leptin receptor expressions in upper mucosa or crypt were examined by flow cytometry. Gray histogram indicates isotype control. Data from a single representative experiment among three independent experiments are shown.
Top 30 genes expressed in cryptal mesenchymal cells.
| Rank | In vivo upper mucosa | In vivo cryptal layer | Ex vivo cryptal layer | Ex vivo upper mucosa | GeneSymbol | Description |
|---|---|---|---|---|---|---|
| 1 | − 0.1352253 | 10.349305 | 1.0953941 | − 0.032011986 | Leptin receptor (Lepr), transcript variant 3, mRNA [NM_001122899] | |
| 2 | − 1.7839279 | 9.163433 | 1.4320621 | − 0.32384896 | Bone morphogenetic protein 5 (Bmp5), mRNA [NM_007555] | |
| 0 | 8.42976 | 0.75516224 | − 1.6026034 | Bone morphogenetic protein 5 (Bmp5), mRNA [NM_007555] | ||
| 3 | − 5.845847 | 8.349145 | 0 | − 1.0225489 | ADAM-like, decysin 1 (Adamdec1), mRNA [NM_021475] | |
| 4 | − 0.036146164 | 7.296133 | 1.1356153 | − 0.10349226 | Protocadherin 12 (Pcdh12), mRNA [NM_017378] | |
| 5 | 0.8064318 | 7.193366 | 0 | − 1.9055712 | GLI-Kruppel family member GLI1 (Gli1), mRNA [NM_010296] | |
| 6 | − 0.31227016 | 7.19128 | 0 | − 1.1451445 | Collagen, type XV, alpha 1 (Col15a1), mRNA [NM_009928] | |
| 7 | − 0.25886297 | 6.7288184 | 1.0249934 | − 0.65438557 | Spectrin repeat containing, nuclear envelope 1 (Syne1), transcript variant 5, mRNA [NM_001347732] | |
| 8 | 0.40697193 | 6.3136005 | 0 | − 1.2896981 | Lin-7 homolog A (C. elegans) (Lin7a), transcript variant 1, mRNA [NM_001039354] | |
| 9 | 4.5943704 | 6.2623343 | 0 | − 2.2177994 | Syntaxin binding protein 6 (amisyn) (Stxbp6), mRNA [NM_144552] | |
| 10 | 0 | 6.2549396 | 1.8562856 | − 1.847434 | Glycine/arginine rich protein 1 (Grrp1), mRNA [NM_001099296] | |
| 11 | 1.4523826 | 5.9267335 | 0 | − 1.1692836 | Cell adhesion molecule 3 (Cadm3), mRNA [NM_053199] | |
| 12 | 0.21515155 | 5.9007926 | 0 | − 2.616846 | – | UI-M-EX0-byj-o-02-0-UI.r1 NIH_BMAP_EX0 cDNA clone IMAGE: 5,719,129 5′, mRNA sequence [CB248850] |
| 13 | 0.17255163 | 5.841345 | 0 | − 1.2357674 | Angiotensin II receptor, type 1b (Agtr1b), mRNA [NM_175086] | |
| 14 | 2.6327944 | 5.812486 | 0 | − 1.8589058 | Interferon regulatory factor 8 [Source:MGI Symbol;Acc:MGI:96395] [ENSMUST00000162775] | |
| 15 | − 2.760572 | 5.737793 | 1.2296844 | − 0.068935394 | PR domain containing 6 (Prdm6), mRNA [NM_001033281] | |
| 16 | − 1.346303 | 5.5345974 | 0.86455584 | − 1.5482342 | Forkhead box L1 (Foxl1), mRNA [NM_008024] | |
| 17 | − 1.9157376 | 5.5081615 | 1.5659752 | − 0.92323875 | Neuronal growth regulator 1 (Negr1), transcript variant 1, mRNA [NM_001039094] | |
| 18 | − 2.9770136 | 5.4516544 | 1.3360395 | − 0.24065113 | Bone morphogenetic protein 4 (Bmp4), transcript variant 1, mRNA [NM_007554] | |
| 19 | − 3.0122108 | 5.441319 | 0.7840228 | − 0.26249528 | Brain expressed, associated with Nedd4, 1 (Bean1), transcript variant 1, mRNA [NM_001141922] | |
| 20 | − 0.8304815 | 5.440546 | 0.45523453 | − 0.61619663 | Latent transforming growth factor beta binding protein 4 (Ltbp4), transcript variant 1, mRNA [NM_175641] | |
| 21 | − 4.281811 | 5.415837 | 0.8549876 | − 0.26267695 | Transcription factor 21 (Tcf21), mRNA [NM_011545] | |
| 22 | 0.30940437 | 5.3867254 | 0 | − 1.0120187 | Contactin 4 (Cntn4), transcript variant 1, mRNA [NM_001109749] | |
| 23 | − 0.0352149 | 5.2685137 | 0.8375006 | − 0.8934727 | Hydrocarboxylic acid receptor 1 (Hcar1), mRNA [NM_175520] | |
| 24 | − 1.1227269 | 5.265641 | 0.48159218 | − 1.4391389 | Neuronal growth regulator 1 (Negr1), transcript variant 2, mRNA [NM_177274] | |
| 25 | 0.41755295 | 5.2641068 | 0 | − 1.005084 | TLR4 interactor with leucine-rich repeats (Tril), mRNA [NM_025817] | |
| 26 | − 0.65405416 | 5.2553177 | 0.27284336 | − 1.1687546 | BEN domain containing 5 (Bend5), transcript variant 1, mRNA [NM_026279] | |
| 27 | 0.6547599 | 5.2338214 | 0 | − 1.1381359 | Ripply transcriptional repressor 3 (Ripply3), mRNA [NM_133229] | |
| 28 | 0 | 5.189296 | 1.0285192 | − 0.7719319 | Wingless-type MMTV integration site family, member 2 (Wnt2), mRNA [NM_023653] | |
| 29 | 0 | 5.1865263 | 0.31024742 | − 1.5084703 | EF hand and coiled-coil domain containing 1 [Source:MGI Symbol;Acc:MGI:3611451] [ENSMUST00000160743] | |
| 30 | 1.6226387 | 5.186082 | 0 | − 1.0252223 | Placenta specific 9a (Plac9a), mRNA [NM_207229] |
Results from in vivo- and ex vivo-expanded mesenchymal cells from the upper mucosa and crypt are shown. Top 30 genes of in vivo mesenchymal cells isolated from cryptal layers are shown.
Figure 4Wnt2b expression is retained in cryptal mesenchymal cells through the LepR. (a) ex vivo cryptal mesenchymal cells were stimulated by leptin or lactate and the expression of cryptal stem niches genes was examined. Relative changes normalized by normalized against the expression of Gapdh were shown. Each dot represents an individual subject (n = 3 or 4) (b,c) Cryptal mesenchymal cells were sorted from control and Lepr mice. (b) The expression of cryptal stem niches genes was examined by qRT-PCR analysis. Each result was normalized against the expression of Gapdh. Each dot represents an individual subject (n = 6 or 7). (c) Colon tissues of control and Lepr mice were stained by Wnt2b and EpCAM. Representative data from 3 mice are shown. Scale bar, 50 μm. (d) The expression of Acta2a was examined by qRT-PCR analysis. Each result was normalized against the expression of Gapdh. Each dot represents an individual subject (n = 6). (e) ex vivo cryptal mesenchymal cells were stimulated by leptin and the expression of Acta2 was examined (n = 6). Data are shown as means ± SEM; *P < 0.05, ***P < 0.01. n.s. indicates not significant.
Figure 5Leptin administration protects intestinal inflammation. (a) Time course of this experiment. Mice underwent DSS treatment, and leptin (1 μg/g) was administered twice daily under fasting conditions to limit intrinsic leptin. (b–d) Representative images and colon length are shown (n = 4 per group). Scale bar, 100 μm. (e) Whole colon cells are isolated and the cell number of EPCAM+ epithelial cells and infiltrated CD11b+ Gr-1+ neutrophils in the colon were shown. *P < 0.05, ***P < 0.01. All data are representative of two independent experiments.
Figure 6Intrinsic leptin controls mucosal healing through LepR+ cryptal mesenchymal cells. (a) Body weight change (n = 4 per group). *P < 0.05. (b) Ratio of control and DSS treated mice colon length are shown. Data are shown as means ± SEM; *P < 0.05. (c) H and E staining of colon on day 6 of DSS treatment is shown. Scale bar, 100 μm. (d) Immunohistochemical analysis of DSS-treated mice on day 6. EdU was administered intraperitoneally 3 h before euthanasia. Tissues were stained with DAPI, EpCAM, and gp38 with detection of proliferated EdU+ cells. Representative data from 4 mice are shown. Scale bar, 100 μm. EdU+ cells counted in per crypt were shown. All data are representative of two independent experiments.
Primer lists for the experiments.
| Forward 5′–3′ | Reverse 5′–3′ | |
|---|---|---|
| Gapdh | TGTCCGTCGTGGATCTGAC | CCTGCTTCACCACCTTCTTG |
| Wnt2b | CCGGGACCACACTGTCTTT | GCTGACGAGATAGCATAGACGA |
| Wnt5a | ACGCTTCGCTTGAATTCCT | CCCGGGCTTAATATTCCAA |
| Rspo3 | TCAAAGGGAGAGCGAGGA | CAGAGGAGGAGCTTGTTTCC |
| Grem1 | GACCCACGGAAGTGACAGA | CCCTCAGCTGTTGGCAGTAG |
| Grem2 | GAGGAGAGGGACAGGGAGAC | AGCGAGAGCTTCCAGAACAT |
| Bmp1 | GAAGGCCATCCATCAAAGC | CCACTAGTGCCCTGACCAC |
| Bmp2 | AGATCTGTACCGCAGGCACT | GTTCCTCCACGGCTTCTTC |
| Bmp4 | GAGGAGTTTCCATCACGAAGA | GCTCTGCCGAGGAGATCA |
| Gli1 | TGGAGGTCTGCGTGGTAGA | TTGAACATGGCGTCTCAGG |
| Foxl1 | CCATGAAGAAGGGACAAAGC | CCACCGGGGAGTCCTAAG |
| Lepr1 | GTTCCAAACCCCAAGAATTG | TGATTCTGCATGCTTGGTAAA |
| Lepr2 | CATTTCCGCTTCAATATCAGG | CCAGCAGAGATGTAGCTGAGAC |
| Lepr3 | GTTCCAAACCCCAAGAATTG | GACTTCAAAGAGTGTCCGTTCTC |
| Leptin | CAGGATCAATGACATTTCACACA | GCTGGTGAGGACCTGTTGAT |
| Hcar1 | GGCTGAGAAAAGCGGTATGA | TCGTTAACTCTCTCCGAGCTAGA |
| Vipr2 | GGCCTGGTGGTAGCAGTTC | TCGCCATCTTCTTTTCAGTTC |
| Adora1 | GTCAAGATCCCTCTCCGGTA | CAAGGGAGAGAATCCAGCAG |
| Agtr1b | CGCCAGCAGCACTGTAGA | GGGGGTGAATTCAAAATGC |
Sequence of primers for the experiments are listed.